Navigation Links
Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis

Drug Effectively Treated 41 to 50% of Patients and Was Well-Tolerated
PRINCETON, NJ, Jun 14, 2007 (MARKET WIRE via COMTEX News Network) -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company that develops and markets dermatology products, today announced results from its completed Phase 2/3 study of liarozole in lamellar ichthyosis, a rare genetic disorder (incidence of approximately 1 in 200,000) which is characterized by a thick scaling of the skin over large body areas. Study results showed liarozole, dosed at 75 mg and 150 mg per day for 12 weeks, was well-tolerated and "effectively treated" the disorder in 41% and 50% of the patients, respectively. The primary efficacy endpoint, "effectively treated," was defined as the percentage of patients that obtained at least a 2 point reduction in investigator's global assessment (IGA) score as defined on a 5 point scale.

The randomized, double-blind, placebo-controlled dose ranging study enrolled 64 patients in three treatment groups. Patients received placebo, 75 mg or 150 mg of liarozole daily for 12 weeks, randomized 1:3:3, respectively. Response rates for the primary endpoint were 41% (11 of 27 patients) for the 75 mg dose, 50% (14 of 28 patients) for the 150 mg dose and 11% (1 of 9 patients) for placebo. The p-values for the 75 and 150 mg per day groups compared to placebo were p=0.2193 and p=0.0557, respectively.

For the secondary endpoints of mean IGA score at week 8 and the overall scaling score at weeks 8 and 12, both liarozole groups achieved statistically significant differences from placebo (p < 0.05). The mean IGA score at week 8 was reduced by 36% and 43% for the 75 and 150 mg liarozole treatment groups, respectively versus 3% for placebo. The mean IGA score for the two liarozole treatment groups continued to improve through 12 weeks. The mean reduction in overall scaling was approximately 45% for both liarozole treatment
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:7/28/2015)... -- Insulet Corporation (NASDAQ: PODD ), the leader in ... Insulin Management System, today announced that Dr. Jessica ... Directors. Dr. Hopfield brings more than two ... She currently serves as the Vice Chair of the ... diabetes research center, diabetes clinic, and provider of diabetes ...
(Date:7/28/2015)... 28, 2015   Regulus Therapeutics Inc . ( ... and development of innovative medicines targeting microRNAs, today announced ... the quarter ended June 30, 2015 on Tuesday, August ... Regulus will host a conference call and ... Eastern Daylight Time to discuss its second quarter 2015 ...
(Date:7/28/2015)... 28, 2015  Psychemedics Corporation (NASDAQ: PMD ) ... ended June 30, 2015.  The Company also announced a ... of record as of August 7, 2015 to be ... Company,s 76 th consecutive quarterly dividend. ... 2015 was $7.0 million versus $7.7 million for the ...
Breaking Medicine Technology:Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Psychemedics Corporation Announces Second Quarter Earnings 2Psychemedics Corporation Announces Second Quarter Earnings 3Psychemedics Corporation Announces Second Quarter Earnings 4Psychemedics Corporation Announces Second Quarter Earnings 5Psychemedics Corporation Announces Second Quarter Earnings 6Psychemedics Corporation Announces Second Quarter Earnings 7Psychemedics Corporation Announces Second Quarter Earnings 8
... 9, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... medical devices worldwide, announced today its selected unaudited financial results ... Highlights for First Quarter 2011 ... over the first quarter of 2010. Robust international sales ...
... 2011 Robotic prostatectomy and prostate cancer ... Urology, and Chief of Robotics and Minimally Invasive Surgery at ... a return to a normal sex life can be achieved ... feature of his signature surgical technique, a majority of men ...
Cached Medicine Technology:Mindray Announces First Quarter 2011 Financial Results 2Mindray Announces First Quarter 2011 Financial Results 3Mindray Announces First Quarter 2011 Financial Results 4Mindray Announces First Quarter 2011 Financial Results 5Mindray Announces First Quarter 2011 Financial Results 6Mindray Announces First Quarter 2011 Financial Results 7Mindray Announces First Quarter 2011 Financial Results 8Mindray Announces First Quarter 2011 Financial Results 9Mindray Announces First Quarter 2011 Financial Results 10Mindray Announces First Quarter 2011 Financial Results 11Mindray Announces First Quarter 2011 Financial Results 12Mindray Announces First Quarter 2011 Financial Results 13Mindray Announces First Quarter 2011 Financial Results 14Is There Sex After Robotic Prostate Surgery? Yes - If You Choose the Right Surgeon and Procedure 2Is There Sex After Robotic Prostate Surgery? Yes - If You Choose the Right Surgeon and Procedure 3
(Date:7/29/2015)... ... July 29, 2015 , ... We are privileged to announce that U.S. News & World ... ninth best ophthalmology hospital in the nation for 2015-2016. This marks the 21st consecutive year ... , “It is an honor to be included in the top 10 ophthalmology hospitals ...
(Date:7/29/2015)... ... July 29, 2015 , ... A June 10, 2015 ... Skin Cancer ," discussed the importance of having regular skin cancer screenings from an ... excessive exposure to ultraviolet rays. When caught early, skin cancer is rarely fatal; however, ...
(Date:7/29/2015)... Viejo, CA (PRWEB) , ... July 29, 2015 , ... ... wipe animations. Designed as drag & drop presets for FCPX, these transitions are easy ... controls, which add versatility to each transition. With over 60 preset styles, kinetic flipping ...
(Date:7/29/2015)... ... ... " mybody ” was featured on NewsWatch as part of its monthly Biz ... in their industry. Andrew Tropeano, the host of NewsWatch and business expert, conducted the ... to strengthen the skin’s defense system from the inside out. , According to Statista, ...
(Date:7/29/2015)... ... July 29, 2015 , ... Indiana is known for basketball, the boyhood ... of Zerorez Indianapolis, which plans to expand across the state. , Ray Kennedy, owner ... full year in business and we should double our first year’s revenue. More ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3
... Metabolic syndrome in children represents a potentially serious threat ... do not have a clear idea of what metabolic ... syndrome is a group of cardiovascular risk factors, including ... Because it is difficult to know when a child ...
... The Pennsylvania Association,of Staff Nurses and Allied ... registered nurses, the California Nurses,Association/National Nurses Organizing Committee ... the affiliation, CNA/NNOC will now represent more than ... 5,100 members., CNA/NNOC and PASNAP have been ...
... Actress and musician joins Jenny Craig to relay the message of a healthy ... ... Inc., one of the,nation,s leading authorities on weight management, held a press conference,today ... company,s newest celebrity client. The Oscar-nominated,singer and actress will be the focal point ...
... against Big ... Tobacco Companies, STUART, Fla., ... Hoffler, Donald Watson and team of the,Florida- based law firm of ... firm will be representing hundreds,of Florida smokers and their families in ...
... biological clock is not as loud as the sound of the ... At least, not right away. , The number of women ... grown tenfold over the past 30 years, coining the moniker: ... titled, Ready: Why Women Are Embracing the New Later Motherhood ...
... chances of developing the disorder , , THURSDAY, Jan. 10 (HealthDay ... role in the development of autism has been identified by ... the gene -- contactin-associated protein-like 2 (CNTNAP2) -- is most ... that the presence of the gene may explain speech delays ...
Cached Medicine News:Health News:Pediatricians call for a cohesive definition of metabolic syndrome in children 2Health News:Pennsylvania's Leading RN Association Joins CNA/NNOC, Nation's Largest Nurses' Union 2Health News:Pennsylvania's Leading RN Association Joins CNA/NNOC, Nation's Largest Nurses' Union 3Health News:Queen Latifah Brings in the New Year with a Healthy Resolution 2Health News:Famed Attorney Willie Gary Files $10.6 Billion in Lawsuits against Big Tobacco Companies on Behalf of Florida Smokers and their Families 2Health News:'Ready': UH prof. chronicles phenomenon of 'new later motherhood' 2Health News:'Ready': UH prof. chronicles phenomenon of 'new later motherhood' 3Health News:Gene Plays Role in Risk of Autism 2Health News:Gene Plays Role in Risk of Autism 3
Transcranial vascular DWL doppler....
Transcranil vascular DWL doppler....
... Imexlab 9100HS is a powerful automated ... vascular assessment. Choose from 6 user-programmable test ... extremity segmental exam. Any tests not included ... can easily be handled using the Doppler, ...
The CD Horizon M10 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
Medicine Products: